Women's Health Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Women's Health Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Breast Cancer
Barriers to minority participation in breast cancer prevention trials identified
September 1st, 2005
In a recent study, barriers to minority participation in breast cancer prevention trials were identified. "Breast carcinoma prevention trials must recruit large cohorts of women who have an above-average risk of developing breast carcinoma," according to researchers from Columbia University in New York. "Recruitment for the Study of Tamoxifen and Raloxifene (STAR) trial required volunteers to complete a risk assessment questionnaire form (RAF)." "Women whose estimated risk of developing breast carcinoma in the next 5 years was {{>=}}1.67% based on the Gail model were invited to participate in STAR," explained V.R. Grann and colleagues. "Less than...
Source: Women's Health Weekly (2005-09-01)
|
